Protocol summary

Study aim
Comparison of urodynamic results of Minimistic intra-detrusor botulinum injection and traditional technique during bladder storage phase in patients with idiopathic over active bladder
Design
Two arm parallel group randomized trial with blinded participants, postoperative care and outcome assessment of 78 patients. Randomization was centralized with balance block randomization using excel software.
Settings and conduct
Patients will be visited by urology residents in Tehran Hasheminezhad kidney center hospital and will be entered into trial according to inclusion and exclusion criteria All observers and analyzers are blind about type of interventions .
Participants/Inclusion and exclusion criteria
-Inclusion criteria: Females more than 18 years old with idiopathic over active bladder with no response to medical therapy or contraindicated ones or the ones who suffering from side effects -Exclusion criteria : Males , females under 18 y/o, overactive bladders due to neurogenic disease
Intervention groups
-In traditional method ( control group ) after general or spinal anesthesia , 0.5 cc Botulinum toxin which has been diluted with 10 cc normal saline is injected into detrusor at 20 sites of bladder (base , laterals and posterior). -In Minimistic method the same diluted Botulinum is injected in 5-6 main sites ( base , laterals and posterior) of bladder under local anesthesia. For local anesthesia 100cc Lidocaine 2% is injected in bladder, 15-20 minutes prior to procedure.
Main outcome variables
Comparison of urodynamic results of Minimistic intra-detrusor botulinum injection and traditional technique during bladder storage phase in patients with idiopathic over active bladder

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20210214050354N1
Registration date: 2022-06-26, 1401/04/05
Registration timing: retrospective

Last update: 2022-06-26, 1401/04/05
Update count: 0
Registration date
2022-06-26, 1401/04/05
Registrant information
Name
Niloofar soleimanifard
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 4462 0947
Email address
n.soleimanifard@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2021-02-19, 1399/12/01
Expected recruitment end date
2022-04-19, 1401/01/30
Actual recruitment start date
2021-02-19, 1399/12/01
Actual recruitment end date
2022-03-19, 1400/12/28
Trial completion date
2022-05-05, 1401/02/15
Scientific title
Comparison of urodynamic results of Minimistic intra-detrusor Botulinum injection and traditional technique during bladder storage phase in patients with idiopathic over active bladder
Public title
Comparison of the efficacy of traditional method and modified technique for Botulinum injection in overactive bladder
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Idiopathic overactive bladders resistant to anticholinergic drugs taking at least four weeks. Anticholinergic medication intolerance due to side effects Anticholinergic contraindications
Exclusion criteria:
Neurogenic bladder due to CVA , Multiple sclerosis, Spinal cord injury , head trauma , Parkinson , disc herniations . Severe bladder outlet obstruction Recurrent UTI Urinary tract anomalies Previous bladder surgery History of pelvic radiation History of pelvic malignancies Pregnancy Age < 18 years old Male
Age
From 18 years old
Gender
Female
Phase
3
Groups that have been masked
  • Participant
  • Outcome assessor
  • Data analyser
Sample size
Target sample size: 78
Actual sample size reached: 78
Randomization (investigator's opinion)
Randomized
Randomization description
Balance block randomization method : -In the present study we used Block randomization that is a commonly used technique in clinical trial design to reduce bias and achieve balance in the allocation of participants to treatment arms, especially when the sample size is small. The basic idea of block randomization is to divide potential patients into m blocks of size 2n, randomize each block such that n patients are allocated to A and n to B. then choose the blocks randomly. This method ensures equal treatment allocation within each block if the complete block is used. -We consist a 3 columns table in Excel . First one is patients' numbers in order to enter the study . Second one is for their randomized group of intervention ( A or B ) and the last one is for the codes we will give to patients to make them and the analyzers blind about types of interventions .
Blinding (investigator's opinion)
Triple blinded
Blinding description
1)Patients 2)Observers who evaluate patients 4-6 weeks after procedures by urodynamic 3) Methodologist who analyzes the final data
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Iran university of medical science
Street address
Hasheminezhad kidney center Hospital , Valinezhad street , Valiasr BLVD, Tehran
City
Tehran
Province
Tehran
Postal code
۱۹۶۹۷۱۴۷۱۳
Approval date
2021-02-27, 1399/12/09
Ethics committee reference number
IR.IUMS.FMD.REC.1399.667

Health conditions studied

1

Description of health condition studied
Idiopathic overactive bladder
ICD-10 code
N00-N99
ICD-10 code description
disease of the genitourinary system

Primary outcomes

1

Description
Comparison of urodynamic results of Minimistic intra-detrusor botulinum injection and traditional technique during bladder storage phase in patients with idiopathic over active bladder
Timepoint
Urodynamic study before Botulinum injection and after 4-6 weeks post injection.
Method of measurement
Urodynamic study

Secondary outcomes

1

Description
Assessing the mean of maximum detrusor pressure in filling phase in traditional method
Timepoint
Before intervention and 4-6 weeks after Botox injection
Method of measurement
Urodynamic study

2

Description
Assessing the mean of maximum detrusor pressure in filling phase in Minimistic method
Timepoint
Before intervention and 4-6 weeks after Botox injection
Method of measurement
Urodynamic study

3

Description
Comparison of the mean of maximum detrusor pressure in filling phase in both Minimistic and traditional methods
Timepoint
Before intervention and 4-6 weeks after Botox injection
Method of measurement
Urodynamic study

4

Description
Assessing the mean of each detrusor over-activity duration in traditional method
Timepoint
Before intervention and 4-6 weeks after Botox injection
Method of measurement
Urodynamic study

5

Description
Assessing the mean of each detrusor over-activity duration in Minimistic method
Timepoint
Before intervention and 4-6 weeks after Botox injection
Method of measurement
Urodynamic study

6

Description
Comparison of the mean of each detrusor over-activity duration in both Minimistic and traditional methods
Timepoint
Before intervention and 4-6 weeks after Botox injection
Method of measurement
Urodynamic study

7

Description
Assessing the mean of bladder capacity in beginning of each detrusor over-activity in traditional method
Timepoint
Before intervention and 4-6 weeks after Botox injection
Method of measurement
Urodynamic study

8

Description
Assessing the mean of bladder capacity in beginning of each detrusor over-activity in Minimistic method
Timepoint
Before intervention and 4-6 weeks after Botox injection
Method of measurement
Urodynamic study

9

Description
Comparison of the mean of bladder capacity in beginning of each detrusor over-activity in both traditional and Minimistic methods
Timepoint
Before intervention and 4-6 weeks after Botox injection
Method of measurement
Urodynamic study

10

Description
Assessing the mean of functional bladder capacity in traditional method
Timepoint
Before intervention and 4-6 weeks after Botox injection
Method of measurement
Urodynamic study

11

Description
Assessing the mean of functional bladder capacity in Minimistic method
Timepoint
Before intervention and 4-6 weeks after Botox injection
Method of measurement
Urodynamic study

12

Description
Comparison of the mean of functional bladder capacity in both traditional and Minimistic methods
Timepoint
Before intervention and 4-6 weeks after Botox injection
Method of measurement
Urodynamic study

13

Description
Assessing the mean of maximum bladder capacity in traditional method
Timepoint
Before intervention and 4-6 weeks after Botox injection
Method of measurement
Urodynamic study

14

Description
Assessing the mean of maximum bladder capacity in Minimistic method
Timepoint
Before intervention and 4-6 weeks after Botox injection
Method of measurement
Urodynamic study

15

Description
Comparison of the mean of maximum bladder capacity in both traditional and Minimistic methods
Timepoint
Before intervention and 4-6 weeks after Botox injection
Method of measurement
Urodynamic study

Intervention groups

1

Description
Control group: As traditional method , spinal or general anesthesia is used. Patients will be hospitalized at least for one day after procedure . In each injection, 0.5 cc Botox are applied by injection at 20 sites of bladder detrusor muscle, mostly in posterior and lateral walls, using Cystoscope . A 500 IU Dysport vial is diluted in 10 cc normal saline for injections.
Category
Treatment - Surgery

2

Description
Intervention group: in Minimistic or the modified method , an oral or IV sedative will be used before procedure. Then 100 cc Lidocaine 2% will be injected in bladder using a 14F Foley catheter. After 15-20 minutes a diluted 500 IU Dysport will be injected at 5-6 main sites, mostly in posterior and lateral walls of bladder, using Cystoscope.
Category
Treatment - Surgery

Recruitment centers

1

Recruitment center
Name of recruitment center
Hasheminejad kidney center
Full name of responsible person
Maryam Emami
Street address
Hasheminejad kidney center , Valinezhad St, Vanak Sq, Tehran, Iran
City
Tehran
Province
Tehran
Postal code
۱۹۶۹۷۱۴۷۱۳
Phone
+98 21 81161
Email
emami59658@yahoo.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Meryam Emami
Street address
Hasheminejad kidney center , Valinezhad St, Vanak Sq, Tehran, Iran
City
Tehran
Province
Tehran
Postal code
۱۹۶۹۷۱۴۷۱۳
Phone
+98 21 81161
Email
n.soleimanifard@gmail.com
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Iran University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Maryam Emami
Position
Assistant professor
Latest degree
Subspecialist
Other areas of specialty/work
Urology
Street address
Hasheminejad kidney center , Valinezhad St, Vanak Sq, Tehran, Iran
City
Tehran
Province
Tehran
Postal code
۱۹۶۹۷۱۴۷۱۳
Phone
+98 21 8116 1532
Email
emami59658@yahoo.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Maryam Emami
Position
Assistant professor
Latest degree
Subspecialist
Other areas of specialty/work
Urology
Street address
Hasheminejad kidney center , Valinezhad St, Vanak Sq, Tehran, Iran
City
Tehran
Province
Tehran
Postal code
۱۹۶۹۷۱۴۷۱۳
Phone
+98 21 8116 1532
Email
emami59658@yahoo.com

Person responsible for updating data

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Niloofar Soleimani Fard
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Urology
Street address
Hasheminejad kidney center , Valinezhad St, Vanak Sq, Tehran, Iran
City
Tehran
Province
Tehran
Postal code
۱۹۶۹۷۱۴۷۱۳
Phone
+98 21 8116 1532
Email
n.soleimanifard@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
Yes - There is a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
Yes - There is a plan to make this available
Data Dictionary
Yes - There is a plan to make this available
Title and more details about the data/document
All data including age , sex and all urodynamic study results can be shared after eliminating private information of the patients.
When the data will become available and for how long
September 2022
To whom data/document is available
Academic researchers
Under which criteria data/document could be used
1)For research only 2)A researcher or an organization who aim to use the results of the present study must precisely refer to this RCT in details.
From where data/document is obtainable
Email address : n.soleimanifard@gmail.com
What processes are involved for a request to access data/document
1)Evaluating the qualification of the applicants 2)Ensuring that the precise title and information of the current study will be mentioned in their studies. 3)After publishing the results as an article, all researchers can benefit from the published manuscript. We also will provide the pdf of the article should a researcher ask at later stages.
Comments
Loading...